Ocean Biomedical, Inc. Quarterly Net Cash Provided by (Used in) Operating Activities in USD from Q2 2021 to Q1 2023

Taxonomy & unit: us-gaap: USD
Description: Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
Summary: Ocean Biomedical, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from Q2 2021 to Q1 2023.
Ocean Biomedical, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2023 was -$2.65M, a 622% decline year-over-year.

Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)

Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)

Period	Value	YoY Chg	Change %	Date	Report	Filed
Q1 2023	-$2.65M	-$2.28M	-622%	Mar 31, 2023	10-Q/A	2024-04-15
Q1 2022	-$367K			Mar 31, 2022	10-Q/A	2024-04-15
Q3 2021	-$708K			Sep 30, 2021	10-Q	2022-10-17
Q2 2021	$40.2K			Jun 30, 2021	10-Q	2022-07-11

* An asterisk sign (*) next to the value indicates that the value is likely invalid.